The US Food and Drug Administration has approved mirdametinib for the treatment of neurofibromatosis type 1 (NF1) in adults ...

In terms of intangible assets, DaVita has built the largest network of dialysis clinics in the US over several decades, based in part on its brand and reputation for high-quality services, extensive ...

Novartis' strong drug pipeline and financials support an 11% annual return by 2027. Learn why NVS stock offers 33% return ...

Over the past nine years, patients with spinal muscular atrophy have seen the number of FDA-approved treatment options for ...

I f you need to fly with medication, you may have a moment of panic while packing, wondering whether you can take pills or ...

(CNN) – The U.S. Food and Drug Administration approved the first new type of pain medication in more than two decades, and it’s not an opioid. The drug is suzetrigine under the brand name ...

The U.S. Food and Drug Administration (FDA) approved Journavx (suzetrigine) oral tablets on Thursday as a first-in-class non-opioid analgesic to treat acute pain in adults. “Today’s approval is an ...

By Apoorva Mandavilli The Trump administration has instructed organizations in other countries to stop disbursing H.I.V. medications purchased with U.S. aid, even if the drugs have already been ...

But, he added, “at such a low price, the quality of the drug may be unreliable,” citing several examples including ... of the same drugs in generic form and found too many similarities ...

The Libertarian Party, which has advocated for drug legalization, had pushed for Ulbricht's release, calling the case an example of government overreach. His arrest brought to an end what ...

Last year, Google Maps on Android was revamped so that the main map view displayed information using sheets, and the entire app is now getting this visual redesign. Instead of place listings being ...

We know that diabetes increases your risk of dementia, for example, so anyone on medication to manage their glucose levels would naturally also be at a higher risk of dementia – but that doesn’t mean ...